Arizona · GLP-1 Telehealth
REMEVi connects Arizona residents with licensed bilingual providers for semaglutide and tirzepatide prescriptions. No insurance required. Free shipping to Phoenix, Tucson, Mesa, and all of Arizona.
Why Arizona
Built for Arizona's diverse, bilingual, and border-state population.
32% of Arizona is Hispanic. All REMEVi care is fully available in English and Spanish — no translators, no compromises.
From the Phoenix metro to Tucson, Yuma, and Flagstaff — REMEVi serves every Arizona city and rural community.
Every REMEVi licensed provider holds an active Arizona medical license and follows Arizona Medical Board telemedicine standards.
Arizona has a high uninsured rate. REMEVi's direct-pay model removes that barrier — transparent pricing, $149 first month, then $279/mo.
How it works
Three simple steps. Bilingual throughout.
Answer a few medical questions from your phone. English or Spanish.
An Arizona-licensed clinician reviews your history and confirms candidacy within 24 hours.
Free, discreet shipping to any Arizona address in 3–5 business days.
Statewide
REMEVi ships to every ZIP code in Arizona. Major cities include:
Arizona is roughly 32% Hispanic and shares a long border with Mexico — bilingual, culturally fluent care isn't optional. REMEVi was built bilingual from day one.
Medications
Compounded semaglutide and tirzepatide from FDA-registered 503B pharmacies.
$149 first month, then $279/mo
A once-weekly GLP-1 injection, with monthly dose adjustments guided by your provider.
Learn more →$249 first month, then $379/mo*
A dual GLP-1 + GIP receptor agonist, linked to higher average weight loss.
Learn more →Pricing
Pay monthly or commit for significant savings. All-inclusive — medication, clinical review, and shipping.
One flat price at every dose. Most weight-loss programs raise your price every time your dose goes up — REMEVi never does. Visit, medication, coaching and shipping — one number. No separate membership fee. (Many programs add a $79–$149/mo membership on top of the medication price.)
Provider-managed weekly injection. The same compounded GLP-1 as the big-brand competitors — with bilingual care, no insurance, no dose upcharges.
Daily oral semaglutide. Same clinical oversight, same bilingual care — without the needle.
Dual-agonist tirzepatide. The strongest average loss in the GLP-1 category — provider-managed, bilingual care.
¹ Clinical-trial results for semaglutide (STEP-1, NEJM 2021) and tirzepatide (SURMOUNT-1, NEJM 2022) — the active medications in REMEVi protocols, not REMEVi outcomes or guarantees. Compounded preparations are not FDA-approved and have not been studied as finished products. Individual results vary.
FAQ
All of Arizona — Phoenix, Tucson, Mesa, Chandler, Gilbert, Scottsdale, Glendale, and beyond.
Yes. All care is available in English and Spanish — important for Arizona's large Hispanic and border community.
Yes. All licensed providers hold active Arizona medical licenses. As of July 2026, 360 clinicians in the REMEVi clinical network hold an active Arizona license.
No. REMEVi is a direct-pay service — $149 for your first month, then $279/month. No insurance required.
Free 1-minute quiz, then a 5-minute intake if you qualify. Arizona-licensed clinical review within 24 hours. Free shipping statewide.
See if you qualify — $149 first monthFree · no card required
